Study
Vitamin B-12 Supplementation Shows No Cognitive or Neurological Improvement in Seniors
Daily vitamin B-12 supplements did not improve memory or nerve function in older adults with moderate deficiency.
Summary
In plain language
In a year-long study, researchers explored whether daily vitamin B-12 supplements could enhance memory and nerve function in seniors over 75 with moderate vitamin B-12 deficiency. Despite initial hopes, the study found that taking a daily dose of 1 mg of vitamin B-12 did not lead to improvements in cognitive or neurological health. This finding is crucial for older adults considering vitamin B-12 supplements for these specific health concerns. It's important to discuss with healthcare providers whether supplementation is necessary and beneficial for individual health needs.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study examined the effects of vitamin B-12 supplementation on cognitive and neurological health in older adults.
Researchers conducted a trial involving seniors aged 75 and over with moderate vitamin B-12 deficiency, who were randomly assigned to receive either a daily vitamin B-12 supplement or a placebo for 12 months.
The study aimed to assess improvements in memory and nerve function, but results showed no significant benefits from the supplementation in these areas.
While the study was rigorously designed, it did not find the anticipated improvements, suggesting that vitamin B-12 may not aid cognitive or neurological health in moderately deficient seniors without anemia.
Seniors should discuss with their healthcare providers whether vitamin B-12 supplementation is appropriate for them, considering individual health circumstances.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Vitamin B-12 Supplementation Shows No Cognitive or Neurological Improvement in Seniors
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 26, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly in study design and bias control due to its RCT structure with blinding and allocation concealment. Statistical integrity was strong with pre-specified endpoints and adequate power. Transparency was high with pre-registration and complete reporting. However, conflicts of interest were not fully transparent, and there was industry involvement. No replication evidence was provided, and journal quality could not be assessed due to lack of information.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 2.5/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized controlled trial investigated the effects of daily vitamin B-12 supplementation on neurological and cognitive function in seniors aged 75+ with moderate vitamin B-12 deficiency. The study found no significant improvements in these functions after 12 months of supplementation compared to placebo.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.